Padmanabhan Chandrasekar, Poddar Aayush
Department of Cardiothoracic Surgery, G.Kuppuswamy Naidu Memorial Hospital, Coimbatore, India.
Indian J Thorac Cardiovasc Surg. 2022 Apr;38(Suppl 1):101-114. doi: 10.1007/s12055-021-01173-6. Epub 2021 May 10.
Infection of the aorta continues to be a clinical challenge with high morbidity and mortality. The incidence varies between 0.6 and 2.6%. There has been a steady increase in graft infections, especially endograft infections, due to increased procedures (0.2 to 5%). species remains the most common organism; however, gram-negative and rare causative agents are also reported. The clinical presentation can be very diverse and a high degree of suspicion is necessary to diagnose them. Sometimes, they may present as an emergency with rupture or fistulation. Diagnosis is based on a triad of clinical features, microbial cultures and imaging. Culture-specific antibiotics are mandatory during the entire course, but seldom cure alone. Surgical management remains the standard of care and involves an integrated approach involving debridement, reconstruction and use of adjuncts. Various aortic substitutes have been described with advantages and limitations. Pericardial tube grafts have emerged as a good option. Endo-vascular options are practiced mostly as a bridge to definitive surgery. A small role for conservative management is described. Aortic fistulation to the gut and airway carries a very high mortality. There are no large series in the literature to define guideline-directed treatment and most often it is a customized solution. The 30-day mortality remains close to 30%. Outcomes depend on multiple factors including patient's age, the timing of presentation, diagnosis, causative organism, host status and the treatment strategy adopted.
主动脉感染仍然是一个具有高发病率和死亡率的临床挑战。发病率在0.6%至2.6%之间。由于手术操作增加(从0.2%至5%),移植物感染,尤其是腔内移植物感染呈稳步上升趋势。[具体]菌种仍然是最常见的病原体;然而,革兰氏阴性菌和罕见病原体也有报道。临床表现可能非常多样,需要高度怀疑才能诊断。有时,它们可能以破裂或形成瘘管的紧急情况出现。诊断基于临床特征、微生物培养和影像学检查三联征。在整个病程中必须使用针对特定培养物的抗生素,但单独使用很少能治愈。手术治疗仍然是标准的治疗方法,包括清创、重建和使用辅助手段的综合方法。已经描述了各种主动脉替代物,各有优缺点。心包管移植物已成为一个不错的选择。血管内治疗方法主要作为确定性手术的桥梁。保守治疗的作用较小。主动脉与肠道和气道形成瘘管的死亡率非常高。文献中没有大型系列研究来定义指南指导的治疗方法,大多数情况下是定制的解决方案。30天死亡率仍接近30%。预后取决于多种因素,包括患者年龄、就诊时间、诊断、病原体、宿主状态和所采用的治疗策略。